Condition

Neuroendocrine Carcinoma of the Lung and Thymus (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

everolimus (1)

pasireotide lar (1)

pasireotide lar and everolimus combination (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

neuroendocrine carcinoma of the lung and thymus

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus

Completed

Neuroendocrine Carcinoma of the Lung and Thymus

Pasireotide LAR
+2 more

Aarhus, Denmark
+35 more

Mar 8, 2021